Merrimack Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MACK and other ETFs, options, and stocks.

About MACK

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. 

CEO
Gary L. Crocker
CEOGary L. Crocker
Employees
—
Employees—
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1993
Founded1993
Employees
—
Employees—

MACK Key Statistics

Market cap
218.41M
Market cap218.41M
Price-Earnings ratio
-181.96
Price-Earnings ratio-181.96
Dividend yield
—
Dividend yield—
Average volume
120.46K
Average volume120.46K
High today
$15.03
High today$15.03
Low today
$14.96
Low today$14.96
Open price
$15.00
Open price$15.00
Volume
206.26K
Volume206.26K
52 Week high
$15.89
52 Week high$15.89
52 Week low
$11.53
52 Week low$11.53

MACK News

Yahoo Finance 2d
Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to ... - Yahoo Finance

Company Updates Potential Range of Initial Liquidating Distribution and Additional Dividend Information CAMBRIDGE, Mass., April 30, 2024--(BUSINESS WIRE)--Merr...

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to ... - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.